$66.58
0.60% yesterday
Nasdaq, Nov 10, 10:00 pm CET
ISIN
US30063P1057
Symbol
EXAS

Exact Sciences Corporation Stock price

$66.58
+8.24 14.12% 1M
+13.18 24.68% 6M
+10.39 18.49% YTD
+15.25 29.71% 1Y
+22.62 51.46% 3Y
-52.20 43.95% 5Y
+56.80 580.78% 10Y
+64.75 3,538.25% 20Y
Nasdaq, Closing price Mon, Nov 10 2025
+0.40 0.60%
ISIN
US30063P1057
Symbol
EXAS
Industry

New AI Insights on Exact Sciences Corporation Insights AI Insights on Exact Sciences Corporation

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$12.5b
Enterprise Value
$14.0b
Net debt
$1.5b
Cash
$858.4m
Shares outstanding
189.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.3 | 3.9
EV/Sales
4.8 | 4.4
EV/FCF
112.5
P/B
5.1
Financial Health
Equity Ratio
40.5%
Return on Equity
-42.8%
ROCE
-2.9%
ROIC
-3.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$2.9b | $3.2b
EBITDA
$66.5m | $467.2m
EBIT
$-150.8m | $-110.7m
Net Income
$-1.0b | $-122.1m
Free Cash Flow
$124.6m
Growth (TTM | estimate)
Revenue
12.6% | 16.7%
EBITDA
175.1% | 377.8%
EBIT
16.9% | 38.2%
Net Income
-474.4% | 88.1%
Free Cash Flow
907.7%
Margin (TTM | estimate)
Gross
68.2%
EBITDA
2.3% | 14.5%
EBIT
-5.1%
Net
-34.2% | -3.8%
Free Cash Flow
4.2%
More
EPS
$-5.3
FCF per Share
$0.7
Short interest
4.8%
Employees
7k
Rev per Employee
$400.0k
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

26x Buy
87%
4x Hold
13%

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

Buy
87%
Hold
13%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,940 2,940
13% 13%
100%
- Direct Costs 935 935
34% 34%
32%
2,005 2,005
5% 5%
68%
- Selling and Administrative Expenses 1,723 1,723
6% 6%
59%
- Research and Development Expense 414 414
10% 10%
14%
66 66
175% 175%
2%
- Depreciation and Amortization 217 217
134% 134%
7%
EBIT (Operating Income) EBIT -151 -151
17% 17%
-5%
Net Profit -1,005 -1,005
474% 474%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
about 12 hours ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) for its previously announced license agreement with Freenome. Under the agreement, the Company acquired exclusive rights in the United States to ...
Positive
The Motley Fool
2 days ago
Exact Sciences' new launches and big ambitions in the cancer market make it an exciting long-term pick. Roku turned a profit for the first time in years, showing that the streaming platform's strategy is bearing fruit.
Neutral
Business Wire
3 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS study (NCT: 05064553). The prospective, head-to-head trial demonstrated that the company's Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinom...
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,950
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today